| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 492 | 2019 |
| A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives M Evans, RD Lewis, AR Morgan, MB Whyte, W Hanif, SC Bain, S Davies, ... Advances in therapy 39 (1), 33-43, 2022 | 116 | 2022 |
| Early mobilisation after percutaneous cardiac catheterisation using collagen plug (VasoSeal) haemostasis. JP Foran, D Patel, J Brookes, RJ Wainwright Heart 69 (5), 424-429, 1993 | 112 | 1993 |
| Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function DC Patel, C Albrecht, D Pavitt, V Paul, C Pourreyron, SP Newman, ... PloS one 6 (7), e22142, 2011 | 101 | 2011 |
| SGLT2 inhibitors in type 2 diabetes management: key evidence and implications for clinical practice J Wilding, K Fernando, N Milne, M Evans, A Ali, S Bain, D Hicks, J James, ... Diabetes Therapy 9, 1757-1773, 2018 | 83 | 2018 |
| SGLT2 inhibitors: cardiovascular benefits beyond HbA1c—translating evidence into practice A Ali, S Bain, D Hicks, P Newland Jones, DC Patel, M Evans, K Fernando, ... Diabetes Therapy 10, 1595-1622, 2019 | 55 | 2019 |
| Elevated lactate levels in patients with poorly regulated type 1 diabetes and glycogenic hepatopathy: a new feature of Mauriac syndrome MCGJ Brouwers, JC Ham, E Wisse, S Misra, S Landewe, M Rosenthal, ... Diabetes care 38 (2), e11-e12, 2015 | 47 | 2015 |
| SGLT2 inhibitors: slowing of chronic kidney disease progression in type 2 diabetes DC Wheeler, J James, D Patel, A Viljoen, A Ali, M Evans, K Fernando, ... Diabetes Therapy 11, 2757-2774, 2020 | 40 | 2020 |
| Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the … D Banerjee, P Winocour, TA Chowdhury, P De, M Wahba, R Montero, ... BMC nephrology 23, 1-31, 2022 | 39 | 2022 |
| Optimising the benefits of SGLT2 inhibitors for type 1 diabetes M Evans, D Hicks, D Patel, V Patel, P McEwan, U Dashora Diabetes Therapy 11, 37-52, 2020 | 38 | 2020 |
| Risk prediction of the diabetes missing million: identifying individuals at high risk of diabetes and related complications M Evans, AR Morgan, D Patel, K Dhatariya, S Greenwood, ... Diabetes Therapy 12, 87-105, 2021 | 31 | 2021 |
| Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation TA Chowdhury, M Wahba, R Mallik, J Peracha, D Patel, P De, D Fogarty, ... Diabetic Medicine 38 (6), e14523, 2021 | 30 | 2021 |
| British infection association guidelines for the diagnosis and management of enteric fever in England LE Nabarro, N McCann, MT Herdman, C Dugan, S Ladhani, D Patel, ... Journal of Infection 84 (4), 469-489, 2022 | 19 | 2022 |
| Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co … U Dashora, R Gregory, P Winocour, K Dhatariya, S Rowles, A Macklin, ... Clinical Medicine 21 (3), 204, 2021 | 19 | 2021 |
| Association between SGLT2 inhibitor treatment and diabetic ketoacidosis and mortality in people with type 2 diabetes admitted to hospital with COVID-19 K Khunti, Y Ruan, J Davies, BCT Field, S Harris, M Kosiborod, D Nagi, ... Diabetes care 45 (12), 2838-2843, 2022 | 16 | 2022 |
| Outcomes with finerenone in participants with stage 4 CKD and type 2 diabetes: a FIDELITY subgroup analysis P Sarafidis, R Agarwal, B Pitt, C Wanner, G Filippatos, J Boletis, KR Tuttle, ... Clinical Journal of the American Society of Nephrology 18 (5), 602-612, 2023 | 14 | 2023 |
| The place and value of sodium-glucose cotransporter 2 inhibitors in the evolving treatment paradigm for type 2 diabetes mellitus: a narrative review JPH Wilding, M Evans, K Fernando, JL Gorriz, A Cebrian, J Diggle, ... Diabetes Therapy 13 (5), 847-872, 2022 | 14 | 2022 |
| Management of hypertension in patients with diabetic kidney disease: summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA … D Banerjee, P Winocour, TA Chowdhury, P De, M Wahba, R Montero, ... Kidney international reports 7 (4), 681-687, 2022 | 14 | 2022 |
| A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post‐COVID‐19 era P Choudhary, EG Wilmot, K Owen, DC Patel, L Mills, G Rayman, ... Diabetic Medicine 38 (3), 2021 | 14 | 2021 |
| Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease J Karalliedde, P Winocour, TA Chowdhury, P De, AH Frankel, ... Diabetic Medicine 39 (4), e14769, 2022 | 10 | 2022 |
